Purified anti-DDX1 Antibody anti-DDX1 - 9F12B04,BioLegend,675302

Host

Mouse

Reactivity

Human, Mouse

Application

WB -Quality testedICC -Verified

Platform ID

BAB983563509

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePurified anti-DDX1 Antibody anti-DDX1 - 9F12B04
Cat. No.675302
HostMouse
RRIDAB_2565509 (BioLegend Cat. No. 675302)
IsotypeMouse IgG1, κ
ReactivityHuman, Mouse
ApplicationWB -Quality testedICC -Verified
ClonalityMonoclonal
Clone Number9F12B04
Concentration0.5 mg/ml
TargetDDX1
ImmunogenPartial human DDX1 recombinant protein (1-107 a.a.) expressed inE. coli.
PurityThe antibody was purified by affinity chromatography.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.
Regulatory StatusResearch Use Only

Scientific Background

DDX1, also known as DEAD box protein retinoblastoma, is a member of the DEAD (Asp-Glu-Ala-Asp)-box RNA helicase family. DDX1 possesses RNA nuclease, binding, unwinding, and ATPase activities, and is thus involved in RNA metabolism, pre-mRNA splicing, translation initiation, and ribosome biogenesis. DDX1 interacts with the Rev protein of HIV-1 and has been shown to be crucial in the viral RNA replication. DDX1 was found to locate to the area of DNA damage induced by ionizing radiation and is implicated to participate in double-strand DNA break repair. DDX1 also acts as a transcriptional coactivator to facilitate NF-κB mediated gene activation. Elevated expression of DDX1 was observed in a number of tumors such as retinoblastoma, neuroblastoma, and testicular carcinoma. The accumulation of DDX1 is associated with cancer metastasis and poor survival.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.